Skip to Content
March 12, 2026 Clouds | 35°F
The 194th General Court of the Commonwealth of Massachusetts

Bill S.819 194th (Current)

An Act prohibiting discrimination against 340b drug discount program participants

By Mr. Payano, a petition (accompanied by bill, Senate, No. 819) of Pavel M. Payano and Joanne M. Comerford for legislation to prohibit discrimination against 340b drug discount program participants. Financial Services.

Bill Information

Presenter:
Pavel M. Payano
Status:
Referred to Joint Committee on Health Care Financing
This bill seeks to protect healthcare providers and pharmacies participating in the federal 340B Drug Pricing Program from unfair reimbursement practices and restrictions imposed by insurers, pharmacy benefit managers (PBMs), and drug manufacturers. It prohibits discriminatory reimbursement rates, additional fees, or conditions that disadvantage 340B covered entities and contract pharmacies compared to non-340B providers. The bill also prevents insurers and PBMs from steering patients away from 340B providers or requiring unnecessary reporting that could hinder program participation. Additionally, it ensures that 340B providers can access discounted drugs without interference from drug manufacturers or distributors. The legislation aims to uphold the integrity of the 340B program, ensuring that safety-net healthcare providers can continue offering affordable medications and services to low-income and underserved populations.
* The bill summary was created by the Primary Sponsor of the bill; no committee of the General Court certifies the accuracy of its contents.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.